reboxetine mesilate - medicine shortage information

Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Sort by: Updated date | Shortage status | Trade name

Product details	Supply Impact Dates	Further Details
EDRONAX reboxetine 4mg (as mesilate) tablet blister pack AUST R: 79745 Active ingredients: reboxetine mesilate Dosage form: Tablet, uncoated Sponsor: Pfizer Australia Pty Ltd Phone: 1800 675 229	From 31 Jan 2025 to 10 Mar 2025	Shortage status: Current Availability: Limited Availability Reason: Manufacturing Management action: Sponsor is working to expedite the next shipment. Patients are advised to consult their healthcare professional to discuss alternative treatment options.

Product details

Supply Impact Dates

Further Details

EDRONAX reboxetine 4mg (as mesilate) tablet blister pack
AUST R: 79745
Active ingredients:
reboxetine mesilate

Dosage form:
Tablet, uncoated

Sponsor:
Pfizer Australia Pty Ltd

Phone:
1800 675 229

From
31 Jan 2025
to
10 Mar 2025

Shortage status:
Current

Availability:
Limited Availability

Reason:
Manufacturing

Management action:
Sponsor is working to expedite the next shipment. Patients are advised to consult their healthcare professional to discuss alternative treatment options.